Akeso, Inc. (HKG: 9926)
Hong Kong
· Delayed Price · Currency is HKD 58.30
-0.30 (-0.51%)
Jan 3, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 53.27 billion as of January 6, 2025. Its market cap has increased by 44.77% in one year.
Market Cap
53.27B
Enterprise Value
53.54B
Revenue
2.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
58.30
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 53.27B, an increase of 187.26%. That is a compound annual growth rate of 25.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2025 | 53.27B | -2.22% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 149.74B |
| Hansoh Pharmaceutical Group Company | 98.87B |
| JD Health International | 84.92B |
| WuXi Biologics | 68.94B |
| Sinopharm Group | 64.91B |
| Innovent Biologics | 58.07B |
| Sino Biopharmaceutical | 55.71B |
| CSPC Pharmaceutical Group | 53.23B |